Monitoring of RAS/EGFR mutations in circulating tumor DNA to guide anti-EGFR therapy in mCRC patients: The CHRONOS trial
Ontology highlight
ABSTRACT: Monitoring of RAS/EGFR mutations in circulating tumor DNA to guide anti-EGFR therapy in mCRC patients: The CHRONOS trial
PROVIDER: PRJEB49484 | ENA |
REPOSITORIES: ENA
ACCESS DATA